AGÕæÈ˹ٷ½

STOCK TITAN

[6-K] IM Cannabis Corp. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

IM Cannabis Corp. (IMCC) closed a C$5.62 million (≈US$4.1 million) private placement on 30 Jul 2025. The company sold 2,050,000 Units at C$2.74 each. Every Unit includes either one common share or one pre-funded warrant plus one five-year warrant exercisable at C$3.43. Pre-funded warrants are exercisable at C$0.00001. All new securities are subject to a four-month hold.

Proceeds are earmarked for working capital, repayment of existing indebtedness and general corporate purposes. IMCC must file a Form F-3 resale registration within 30 days and seek effectiveness within 60/90 days, depending on SEC review.

Pure Equity advised on the transaction and receives a one-time US$260,000 cash fee and 140,000 five-year warrants exercisable at US$2.50.

The deal strengthens liquidity but introduces potential dilution through the issuance of new shares, warrants and advisor compensation.

IM Cannabis Corp. (IMCC) ha chiuso un collocamento privato da 5,62 milioni di dollari canadesi (circa 4,1 milioni di dollari USA) il 30 luglio 2025. La società ha venduto 2.050.000 unità a 2,74 dollari canadesi ciascuna. Ogni unità include una azione ordinaria o un warrant prefinanziato, oltre a un warrant quinquennale esercitabile a 3,43 dollari canadesi. I warrant prefinanziati sono esercitabili a 0,00001 dollari canadesi. Tutti i nuovi titoli sono soggetti a un periodo di lock-up di quattro mesi.

I proventi sono destinati al capitale circolante, al rimborso del debito esistente e a scopi societari generali. IMCC deve presentare un modulo F-3 per la registrazione della rivendita entro 30 giorni e ottenere l’efficacia entro 60/90 giorni, a seconda della revisione della SEC.

Pure Equity ha fornito consulenza per l’operazione e riceve una commissione una tantum in contanti di 260.000 dollari USA e 140.000 warrant quinquennali esercitabili a 2,50 dollari USA.

L’operazione rafforza la liquidità ma introduce un potenziale effetto diluitivo attraverso l’emissione di nuove azioni, warrant e la remunerazione del consulente.

IM Cannabis Corp. (IMCC) cerró una colocación privada por 5,62 millones de dólares canadienses (aproximadamente 4,1 millones de dólares estadounidenses) el 30 de julio de 2025. La empresa vendió 2.050.000 unidades a 2,74 dólares canadienses cada una. Cada unidad incluye una acción común o un warrant prefinanciado, además de un warrant a cinco años ejercitable a 3,43 dólares canadienses. Los warrants prefinanciados se pueden ejercer a 0,00001 dólares canadienses. Todos los nuevos valores están sujetos a un período de retención de cuatro meses.

Los fondos se destinarán a capital de trabajo, pago de deudas existentes y propósitos corporativos generales. IMCC debe presentar un formulario F-3 para el registro de reventa dentro de los 30 días y buscar la efectividad dentro de 60/90 días, según la revisión de la SEC.

Pure Equity asesoró en la transacción y recibe una comisión única en efectivo de 260.000 dólares estadounidenses y 140.000 warrants a cinco años ejercitables a 2,50 dólares estadounidenses.

El acuerdo fortalece la liquidez, pero introduce una posible dilución mediante la emisión de nuevas acciones, warrants y la compensación del asesor.

IM Cannabis Corp. (IMCC)ëŠ� 2025ë…� 7ì›� 30ì¼ì— 562ë§� ìºë‚˜ë‹� 달러(ì•� 410ë§� 미국 달러) 규모ì� 사모 ë°°ì •ì� 완료했습니다. 회사ëŠ� 단위ë‹� 2.74 ìºë‚˜ë‹� 달러ì—� 2,050,000 단위ë¥� íŒë§¤í–ˆìŠµë‹ˆë‹¤. ê°� 단위ì—는 보통ì£� 1ì£� ë˜ëŠ” 선행행사 워런íŠ� 1개와 행사 ê°€ê²� 3.43 ìºë‚˜ë‹� 달러ì� 5ë…� 만기 워런íŠ� 1개가 í¬í•¨ë˜ì–´ 있습니다. 선행행사 워런트는 0.00001 ìºë‚˜ë‹� 달러ì—� 행사í•� ìˆ� 있습니다. 모든 ì‹ ê·œ ì¦ê¶Œì€ 4개월ê°� ë§¤ë„ ì œí•œì� ì ìš©ë©ë‹ˆë‹�.

ìžê¸ˆì€ ìš´ì „ìžë³¸, 기존 ë¶€ì±� ìƒí™˜ ë°� ì¼ë°˜ 기업 목ì ì—� 사용ë� 예정입니ë‹�. IMCCëŠ� 30ì� ì´ë‚´ì—� F-3 ì–‘ì‹ ìž¬íŒë§� 등ë¡ì� 제출하고, SEC 심사ì—� ë”°ë¼ 60/90ì� ì´ë‚´ì—� 효력 ë°œìƒì� 신청해야 합니ë‹�.

Pure Equityê°€ 거래 ìžë¬¸ì� 맡았으며, ì¼íšŒì„� 현금 수수ë£� 26ë§� 미국 달러와 행사 ê°€ê²� 2.50 미국 달러ì� 5ë…� 만기 워런íŠ� 140,000개를 받습니다.

ì´ë²ˆ 거래ëŠ� 유ë™ì„±ì„ 강화하지ë§�, ì‹ ê·œ ì£¼ì‹ ë°œí–‰, 워런íŠ� ë°� ìžë¬¸ ë³´ìƒìœ¼ë¡œ ì¸í•´ í¬ì„ 가능성ë� 있습니다.

IM Cannabis Corp. (IMCC) a clôturé un placement privé de 5,62 millions de dollars canadiens (environ 4,1 millions de dollars US) le 30 juillet 2025. La société a vendu 2 050 000 unités à 2,74 dollars canadiens chacune. Chaque unité comprend soit une action ordinaire, soit un bon de souscription préfinancé, ainsi qu’un bon de souscription de cinq ans exerçable à 3,43 dollars canadiens. Les bons de souscription préfinancés sont exerçables à 0,00001 dollar canadien. Tous les nouveaux titres sont soumis à une période de blocage de quatre mois.

Les fonds seront affectés au fonds de roulement, au remboursement des dettes existantes et à des fins générales d’entreprise. IMCC doit déposer un formulaire F-3 pour l’enregistrement de revente dans les 30 jours et viser une mise en vigueur sous 60/90 jours, selon l’examen de la SEC.

Pure Equity a conseillé dans cette opération et reçoit une commission unique en espèces de 260 000 dollars US ainsi que 140 000 bons de souscription de cinq ans exerçables à 2,50 dollars US.

Cette opération renforce la liquidité mais entraîne un risque potentiel de dilution via l’émission de nouvelles actions, de bons de souscription et la rémunération du conseiller.

IM Cannabis Corp. (IMCC) hat am 30. Juli 2025 eine Privatplatzierung über 5,62 Millionen kanadische Dollar (ca. 4,1 Millionen US-Dollar) abgeschlossen. Das Unternehmen verkaufte 2.050.000 Einheiten zu je 2,74 kanadischen Dollar. Jede Einheit umfasst entweder eine Stammaktie oder einen vorausbezahlten Warrant sowie einen fünfjährigen Warrant mit Ausübungspreis von 3,43 kanadischen Dollar. Vorausbezahlte Warrants sind zu 0,00001 kanadischen Dollar ausübbar. Alle neuen Wertpapiere unterliegen einer viermonatigen Haltefrist.

Die Erlöse sind für das Betriebskapital, die Rückzahlung bestehender Verbindlichkeiten und allgemeine Unternehmenszwecke vorgesehen. IMCC muss innerhalb von 30 Tagen eine Form F-3 für die Wiederverkaufsregistrierung einreichen und je nach SEC-Prüfung innerhalb von 60/90 Tagen die Wirksamkeit anstreben.

Pure Equity beriet bei der Transaktion und erhält eine einmalige Barvergütung von 260.000 US-Dollar sowie 140.000 fünfjährige Warrants mit einem Ausübungspreis von 2,50 US-Dollar.

Der Deal stärkt die Liquidität, bringt jedoch potenzielle Verwässerung durch die Ausgabe neuer Aktien, Warrants und Beratervergütung mit sich.

Positive
  • C$5.6 million cash infusion enhances liquidity for working capital and debt reduction.
  • Warrants priced above unit cost reduce immediate dilution risk and could provide additional capital if exercised.
Negative
  • Issuance of 2.05 million shares and warrants dilutes existing shareholders.
  • Advisor compensation of US$260k and 140k warrants adds cost and further dilution.

Insights

TL;DR 25 words: Small capital raise boosts cash but adds dilution; warrants priced above market, neutral net effect on valuation and leverage.

The C$5.6 million injection improves near-term liquidity, providing funds for working capital and debt service without high-interest borrowing. However, 2.05 million shares and an equal number of C$3.43 warrants, plus 140k advisor warrants, enlarge the fully diluted share count and cap table complexity. The warrant strike lies above the unit price, suggesting investors bet on upside but also limiting immediate conversion pressure. Filing deadlines for resale registration create administrative obligations but no cash outflow. At ~US$4.1 million, the raise is modest relative to typical industry burn rates; impact is therefore neutral overall.

IM Cannabis Corp. (IMCC) ha chiuso un collocamento privato da 5,62 milioni di dollari canadesi (circa 4,1 milioni di dollari USA) il 30 luglio 2025. La società ha venduto 2.050.000 unità a 2,74 dollari canadesi ciascuna. Ogni unità include una azione ordinaria o un warrant prefinanziato, oltre a un warrant quinquennale esercitabile a 3,43 dollari canadesi. I warrant prefinanziati sono esercitabili a 0,00001 dollari canadesi. Tutti i nuovi titoli sono soggetti a un periodo di lock-up di quattro mesi.

I proventi sono destinati al capitale circolante, al rimborso del debito esistente e a scopi societari generali. IMCC deve presentare un modulo F-3 per la registrazione della rivendita entro 30 giorni e ottenere l’efficacia entro 60/90 giorni, a seconda della revisione della SEC.

Pure Equity ha fornito consulenza per l’operazione e riceve una commissione una tantum in contanti di 260.000 dollari USA e 140.000 warrant quinquennali esercitabili a 2,50 dollari USA.

L’operazione rafforza la liquidità ma introduce un potenziale effetto diluitivo attraverso l’emissione di nuove azioni, warrant e la remunerazione del consulente.

IM Cannabis Corp. (IMCC) cerró una colocación privada por 5,62 millones de dólares canadienses (aproximadamente 4,1 millones de dólares estadounidenses) el 30 de julio de 2025. La empresa vendió 2.050.000 unidades a 2,74 dólares canadienses cada una. Cada unidad incluye una acción común o un warrant prefinanciado, además de un warrant a cinco años ejercitable a 3,43 dólares canadienses. Los warrants prefinanciados se pueden ejercer a 0,00001 dólares canadienses. Todos los nuevos valores están sujetos a un período de retención de cuatro meses.

Los fondos se destinarán a capital de trabajo, pago de deudas existentes y propósitos corporativos generales. IMCC debe presentar un formulario F-3 para el registro de reventa dentro de los 30 días y buscar la efectividad dentro de 60/90 días, según la revisión de la SEC.

Pure Equity asesoró en la transacción y recibe una comisión única en efectivo de 260.000 dólares estadounidenses y 140.000 warrants a cinco años ejercitables a 2,50 dólares estadounidenses.

El acuerdo fortalece la liquidez, pero introduce una posible dilución mediante la emisión de nuevas acciones, warrants y la compensación del asesor.

IM Cannabis Corp. (IMCC)ëŠ� 2025ë…� 7ì›� 30ì¼ì— 562ë§� ìºë‚˜ë‹� 달러(ì•� 410ë§� 미국 달러) 규모ì� 사모 ë°°ì •ì� 완료했습니다. 회사ëŠ� 단위ë‹� 2.74 ìºë‚˜ë‹� 달러ì—� 2,050,000 단위ë¥� íŒë§¤í–ˆìŠµë‹ˆë‹¤. ê°� 단위ì—는 보통ì£� 1ì£� ë˜ëŠ” 선행행사 워런íŠ� 1개와 행사 ê°€ê²� 3.43 ìºë‚˜ë‹� 달러ì� 5ë…� 만기 워런íŠ� 1개가 í¬í•¨ë˜ì–´ 있습니다. 선행행사 워런트는 0.00001 ìºë‚˜ë‹� 달러ì—� 행사í•� ìˆ� 있습니다. 모든 ì‹ ê·œ ì¦ê¶Œì€ 4개월ê°� ë§¤ë„ ì œí•œì� ì ìš©ë©ë‹ˆë‹�.

ìžê¸ˆì€ ìš´ì „ìžë³¸, 기존 ë¶€ì±� ìƒí™˜ ë°� ì¼ë°˜ 기업 목ì ì—� 사용ë� 예정입니ë‹�. IMCCëŠ� 30ì� ì´ë‚´ì—� F-3 ì–‘ì‹ ìž¬íŒë§� 등ë¡ì� 제출하고, SEC 심사ì—� ë”°ë¼ 60/90ì� ì´ë‚´ì—� 효력 ë°œìƒì� 신청해야 합니ë‹�.

Pure Equityê°€ 거래 ìžë¬¸ì� 맡았으며, ì¼íšŒì„� 현금 수수ë£� 26ë§� 미국 달러와 행사 ê°€ê²� 2.50 미국 달러ì� 5ë…� 만기 워런íŠ� 140,000개를 받습니다.

ì´ë²ˆ 거래ëŠ� 유ë™ì„±ì„ 강화하지ë§�, ì‹ ê·œ ì£¼ì‹ ë°œí–‰, 워런íŠ� ë°� ìžë¬¸ ë³´ìƒìœ¼ë¡œ ì¸í•´ í¬ì„ 가능성ë� 있습니다.

IM Cannabis Corp. (IMCC) a clôturé un placement privé de 5,62 millions de dollars canadiens (environ 4,1 millions de dollars US) le 30 juillet 2025. La société a vendu 2 050 000 unités à 2,74 dollars canadiens chacune. Chaque unité comprend soit une action ordinaire, soit un bon de souscription préfinancé, ainsi qu’un bon de souscription de cinq ans exerçable à 3,43 dollars canadiens. Les bons de souscription préfinancés sont exerçables à 0,00001 dollar canadien. Tous les nouveaux titres sont soumis à une période de blocage de quatre mois.

Les fonds seront affectés au fonds de roulement, au remboursement des dettes existantes et à des fins générales d’entreprise. IMCC doit déposer un formulaire F-3 pour l’enregistrement de revente dans les 30 jours et viser une mise en vigueur sous 60/90 jours, selon l’examen de la SEC.

Pure Equity a conseillé dans cette opération et reçoit une commission unique en espèces de 260 000 dollars US ainsi que 140 000 bons de souscription de cinq ans exerçables à 2,50 dollars US.

Cette opération renforce la liquidité mais entraîne un risque potentiel de dilution via l’émission de nouvelles actions, de bons de souscription et la rémunération du conseiller.

IM Cannabis Corp. (IMCC) hat am 30. Juli 2025 eine Privatplatzierung über 5,62 Millionen kanadische Dollar (ca. 4,1 Millionen US-Dollar) abgeschlossen. Das Unternehmen verkaufte 2.050.000 Einheiten zu je 2,74 kanadischen Dollar. Jede Einheit umfasst entweder eine Stammaktie oder einen vorausbezahlten Warrant sowie einen fünfjährigen Warrant mit Ausübungspreis von 3,43 kanadischen Dollar. Vorausbezahlte Warrants sind zu 0,00001 kanadischen Dollar ausübbar. Alle neuen Wertpapiere unterliegen einer viermonatigen Haltefrist.

Die Erlöse sind für das Betriebskapital, die Rückzahlung bestehender Verbindlichkeiten und allgemeine Unternehmenszwecke vorgesehen. IMCC muss innerhalb von 30 Tagen eine Form F-3 für die Wiederverkaufsregistrierung einreichen und je nach SEC-Prüfung innerhalb von 60/90 Tagen die Wirksamkeit anstreben.

Pure Equity beriet bei der Transaktion und erhält eine einmalige Barvergütung von 260.000 US-Dollar sowie 140.000 fünfjährige Warrants mit einem Ausübungspreis von 2,50 US-Dollar.

Der Deal stärkt die Liquidität, bringt jedoch potenzielle Verwässerung durch die Ausgabe neuer Aktien, Warrants und Beratervergütung mit sich.



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of July 2025 (Report No. 4).
 
Commission File Number: 001-40065

IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒  Form 40-F
 


CONTENTS

Private Placement Offering
 
On July 30, 2025, IM Cannabis Corp. (the “Company”) entered into subscription agreements (the “Subscription Agreements”) for a private placement financing with certain investors (the “Offering”). Under the Subscription Agreements, the investors have agreed to purchase an aggregate of 2,050,000 units (each a “Unit”, and collectively, the “Units”) at a purchase price of C$2.74 per Unit. Each Unit consists of one common share of the Company, no par value per share (the “Common Shares”), or one common share pre-funded warrant in lieu thereof (the “Pre-Funded Warrants”), and one common share purchase warrant (the “Warrants”).
 
The Offering amount and Unit price were calculated based on the official exchange rate as of July 21, 2025, of 1 USD = 1.3713 CAD (USD/ILS = 3.3550; CAD/ILS = 2.4465) as published on the website of the Bank of Israel (the “Exchange Rate”).
 
Each Warrant entitles its holder to purchase one Common Share (each, a “Warrant Share”) at an exercise price of C$3.43 per Warrant Share, became exercisable immediately upon issuance and for a period of sixty (60) months from its issuance. If the Warrants are not exercised by the applicable expiry date, the Warrants will expire and be of no further force or effect. The Warrants and the Warrant Shares may not be traded for a period of four (4) months, unless permitted under applicable securities legislation.
 
Each Pre-Funded Warrant entitles its holder to purchase one Common Share (each, a “Pre-Funded Share”) at a price of C$0.00001 per Pre-Funded Share, became exercisable immediately upon issuance and may be exercised at any time until exercised in full. The Pre-Funded Warrants and the Pre-Funded Warrant Shares may not be traded for a period of four (4) months, unless permitted under applicable securities legislation.
 
The Offering resulted in gross proceeds to the Company of C$5,622,522, which the Company intends to use for general working capital, repayment of existing indebtedness and general corporate purposes. The Offering closed on July 30, 2025.
 
Pursuant to the Subscription Agreement, the Company has agreed to file a resale registration statement on Form F-3 (or other available form) (the “Registration Statement”) providing for the resale by the purchasers of the Common Shares, the Warrant Shares, the Pre-Funded Shares and the Finder’s Warrant Shares (as defined below) within thirty (30) calendar days of the Closing Date. The Company also agreed to use commercially reasonable efforts to cause such Registration Statement to become effective as soon as practicable, but in no event later than the date, which shall be either: (i) in the event that the U.S. Securities and Exchange Commission does not review the Registration Statement, sixty (60) calendar days after the Closing Date, or (ii) in the event that the U.S. Securities and Exchange Commission reviews the Registration Statement, ninety (90) days after the Closing Date.
 
The foregoing summaries of the Subscription Agreements, the Warrants and the Pre-Funded Warrants do not purport to be complete and are qualified in their entirety by reference to the Form of Subscription Agreement (Non-US Investors), Form of Subscription Agreement (US Investors), Form of Common Warrant and Form of Pre-Funded Warrant, which are attached as Exhibits 99.1, 99.2, 99.3, and 99.4, respectively, to this Report of Foreign Private Issuer on Form 6-K and are incorporated herein by reference.
 

 
Advisory Agreement
 
In connection with the Offering, on July 31, 2025, the Company entered into a Consulting Agreement (the “Consulting Agreement”) with Pure Equity Ltd. (“Pure Equity”), pursuant to which Pure Equity provided the Company with consulting services related to the Offering. In consideration of the consulting services, the Company issued to Pure Equity a warrant (the “Finder’s Warrant”) to purchase up to 140,000 common shares of the Company (the “Finder’s Warrant Shares”). In addition, pursuant to the Consulting Agreement, Pure Equity shall be entitled to a one-time cash payment of $260,000 plus applicable taxes.
 
The Finder’s Warrant has an exercise price of US$2.50 per Finder’s Warrant Share, became exercisable immediately upon issuance and for a period of sixty (60) months following its issuance. The Finder’s Warrant and the Finder’s Warrant Share may not be traded for a period of four (4) months, unless permitted under applicable securities legislation.
 
The foregoing summaries of the Advisory Agreement and the Finder’s Warrant do not purport to be complete and are qualified in their entirety by reference to the Advisory Agreement and the Form of Finder’s Warrants, which are attached as Exhibits 99.5 and 99.6, respectively, to this Report of Foreign Private Issuer on Form 6-K and are incorporated herein by reference.

The securities described herein have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and may not be sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
 
This Report of Foreign Private Issuer on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
 
Press Release
 
On July 31, 2025, the Company issued a press release titled: “IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million”. A copy of this press release is furnished herewith as Exhibit 99.7.
 
Incorporation by Reference
 
This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-288346) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.


 
EXHIBIT INDEX
 
Exhibit No.
 
99.1
Form of Subscription Agreement (Non-US Investors)
99.2
Form of Subscription Agreement (US Investors)
99.3
Form of Common Warrant
99.4
Form of Pre-Funded Warrant
99.5
Advisory Agreement, dated July 31, 2025, by and between the Company and Pure Equity
99.6
Form of Finder’s Warrant
99.7
Press Release, dated July 31, 2025, titled “IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million”



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
IM CANNABIS CORP.
 
(Registrant)
 
 
 
Date: July 31, 2025
By:
/s/ Oren Shuster
 
Name:   
Oren Shuster
 
Title:
Chief Executive Officer and Director


FAQ

How much capital did IMCC raise in the July 2025 private placement?

The company raised C$5,622,522 (≈US$4.1 million) in gross proceeds.

What securities were issued in IM Cannabis's private placement?

Investors bought 2,050,000 Units, each containing one common share or pre-funded warrant and one five-year warrant at C$3.43.

When do the newly issued warrants expire?

Both the investor warrants and the 140,000 advisor warrants are exercisable immediately and expire 60 months from issuance.

What will IMCC use the private placement proceeds for?

Proceeds are allocated to general working capital, repayment of existing indebtedness and corporate purposes.

When will IM Cannabis file the resale registration statement?

IMCC must file a Form F-3 registration within 30 days of the 30 Jul 2025 closing date.

What compensation did Pure Equity receive for advising on the deal?

Pure Equity receives a US$260,000 cash fee and 140,000 warrants exercisable at US$2.50 for five years.
Im Cannabis Corp

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Latest SEC Filings

IMCC Stock Data

10.84M
1.70M
43.88%
3.91%
0.26%
Drug Manufacturers - Specialty & Generic
Healthcare
Israel
Tel Aviv